Basal and therapy-driven hypoxia-inducible factor-1α confers resistance to endocrine therapy in estrogen receptor-positive breast cancer
Xiaoqing Jia(Fudan University Shanghai Cancer Center), Guang‐Yu Liu(Fudan University Shanghai Cancer Center)
Cited by 37
Related Papers
Zoledronic acid sensitizes breast cancer cells to fulvestrant via ERK/HIF-1 pathway inhibition in�vivo
|Molecular Medicine Reports|2018|5